Cezary Swider

1.4k citations

20 papers · 1.1k indexed · h-index 11

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 14
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 3
Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2

Co-authors: Martin Carroll Robin Perry Kathleen M. Murphy Gwenn Danet-Desnoyers Jean‐Emmanuel Sarry Alexander E. Perl Andrzej Lange Elizabeth O. Hexner
Journals: Blood (7 papers)Clinical Cancer Research (2 papers)mAbs (1 paper)Cancer Biology & Therapy (1 paper)Clinical & Experimental Immunology (1 paper)
Partner nations: United States Poland Germany

In The Last Decade

Cezary Swider

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Cezary Swider

Since Specialization

Citations

This map shows the geographic impact of Cezary Swider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cezary Swider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cezary Swider more than expected).

Fields of papers citing papers by Cezary Swider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cezary Swider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cezary Swider. The network helps show where Cezary Swider may publish in the future.

Co-authors

The 25 scholars most cited alongside Cezary Swider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cezary Swider Line = papers co-authored together Cezary Swider links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation mAbs ·John P. Dowling, Pavel A. Nikitin, Fang Shen, Halley Shukla, James P. Finn, Nirja Patel, Cezary Swider, Jamie L. Bingaman-Steele, Chris Nicolescu, Eden L. Sikorski, Evan J. Greenawalt, Michael J. Morin, Matthew K. Robinson, Karen Lundgren, Benjamin C. Harman	2023	7
2	Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma Blood ·Dan T. Vogl, Edward A. Stadtmauer, James E. Bradner, Lisa E. Davis, Thomas Paul, Emma Scott, Charles W. Nichols, David Porter, Martin Carroll, Janeen Kaplan, G. Mallon, Cezary Swider, Patricia Mangan, Brenda K. Shelly, Ravi K. Amaravadi	2011	3
3	Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice Journal of Clinical Investigation ·Jean‐Emmanuel Sarry, Kathleen M. Murphy, Robin Perry, Patricia Vanessa Sanchez, Anthony Secreto, Cathy Keefer, Cezary Swider, Anne-Claire Strzelecki, Cindy Cavelier, Christian Récher, Véronique Mansat‐De Mas, Éric Delabesse, Gwenn Danet-Desnoyers, Martin Carroll	2010	280
4	Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming Oncogene ·Fanyu Zhao, Anthony Mancuso, Thi Bui, Xiangmin Tong, Joshua J. Gruber, Cezary Swider, P V Sanchez, Julian J. Lum, Nadia Yasmina Ben Sayed, J V Melo, Alexander E. Perl, Martin Carroll, S.W. Tuttle, Craig B. Thompson	2010	150
5	A robust xenotransplantation model for acute myeloid leukemia Leukemia ·P V Sanchez, Robin Perry, Jean‐Emmanuel Sarry, Alexander E. Perl, Kathleen M. Murphy, Cezary Swider, Adam Bagg, John Choi, Jaclyn A. Biegel, Gwenn Danet-Desnoyers, Martin Carroll	2009	86
6	A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia Clinical Cancer Research ·Alexander E. Perl, Margaret Kasner, Donald E. Tsai, Dan T. Vogl, Alison W. Loren, Stephen J. Schuster, David L. Porter, Edward A. Stadtmauer, Steven C. Goldstein, Noelle V. Frey, Sunita D. Nasta, Elizabeth O. Hexner, Jamil Dierov, Cezary Swider, Adam Bagg, Alan M. Gewirtz, Martin Carroll, Selina M. Luger	2009	82
7	Effect of Obesity and Renal Insufficiency On Toxicity of High-Dose Melphalan for Multiple Myeloma. Blood ·Dan T. Vogl, Thomas Paul, Eric T. Stoopler, German Salazar, Lisa E. Davis, Shiv Kapoor, Babette S. Zemel, Mark Yudkoff, Gail Jackson, Lisa Basel-Brown, Kenneth Rockwell, Evgueni Daikhin, Cezary Swider, John L. Washington, Maria Raguza-Lopez, Thomas R. TenHave, Edward A. Stadtmauer	2009	1
8	A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia Clinical Cancer Research ·Donald E. Tsai, Selina M. Luger, Charalambos Andreadis, Dan T. Vogl, Allison Kemner, Melissa Potuzak, Ami Goradia, Alison W. Loren, Alexander E. Perl, Stephen J. Schuster, David L. Porter, Edward A. Stadtmauer, Steven C. Goldstein, James E. Thompson, Cezary Swider, Adam Bagg, Anthony R. Mato, Martin Carroll	2008	29
9	Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene Cancer Biology & Therapy ·Donald E. Tsai, Selina M. Luger, Allison Kemner, Cezary Swider, Ami Goradia, Ewa Tomczak, Doris DiPatri, Adam Bagg, Peter C. Nowell̀, Alison W. Loren, Alexander E. Perl, Stephen J. Schuster, James E. Thompson, David Porter, Charlambos Andreadis, Edward A. Stadtmauer, Steven Goldstein, Richard Ghalie, Martin Carroll	2007	6
10	Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders Blood ·Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan, Cezary Swider, Candy Robinson, Yang Shi, Thelma S. Angeles, Stephen G. Emerson, Martin Carroll, Bruce Ruggeri, Paweł Dobrzański	2007	202
11	CEP-701 Is a JAK2 Inhibitor Which Attenuates JAK2/STAT5 Signaling Pathway and the Proliferation of Primary Cells from Patients with Myeloproliferative Disorders. Blood ·Paweł Dobrzański, Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan, Cezary Swider, Candy Robinson, Shi Qui Yang, Thelma S. Angeles, Stephen G. Emerson, Martin Carroll, Bruce Ruggeri	2006	17
12	The Proto-Oncogene Myb Augments Transcription of the Neuropeptide Neuromedin U in Human Myeloid Leukemias. Blood ·Susan E. Shetzline, Joseph Patrick Conlon, Cezary Swider, Lindsay Thalheim, Alan M. Gewirtz	2006	1
13	modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing Anna Kalota, Lidia Karabon, Cezary Swider, Ekaterina Viazovkina, Mohamed I. Elzagheid, Masad J. Damha, Alan M. Gewirtz	2006	0
14	Transcriptional Regulation of the Intra-S-Phase Regulator CDC7 in Human Myeloid Leukemic Cells: A New Downstream Target of the C-Myb Protooncogene. Blood ·Lindsay Thalheim, Susan E. Shetzline, Cezary Swider, Alan M. Gewirtz	2005	2
15	Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias Blood ·Susan E. Shetzline, Ravikumar Rallapalli, Kelley J. Dowd, Shaomin Zou, Yuji Nakata, Cezary Swider, Anna Kalota, John Choi, Alan M. Gewirtz	2004	44
16	TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. PubMed ·Cezary Swider, Leonhard Schnittger, Katarzyna Bogunia‐Kubik, Johannes Gerdes, H.-D. Flad, Andrzej Lange, Ulrike Seitzer	1999	64
17	TUMOUR NECROSIS FACTOR ALPHA PROMOTER GENE POLYMORPHISM IN SARCOIDOSIS Cytokine ·Ulrike Seitzer, Cezary Swider, Frank Stüber, Krzysztof Suchnicki, Andrzej Lange, Elvira Richter, P. Zabel, Joachim Müller‐Quernheim, Hans‐Dieter Flad, Johannes Gerdes	1997	109
18	Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients. PubMed ·Andrzej Lange, Lidia Karabon, Aleksandra Klimczak, Dorota Dłubek, Katarzyna Bogunia‐Kubik, Cezary Swider, Krzysztof Suchnicki	1996	8
19	IL‐6 Is Present in Sera of Bone Marrow—transplanted Patients in Aplastic Period and High Levels of IL‐6 during Acute Graft‐versus‐Host Disease Are Associated with Severe Gut Symptomsa Annals of the New York Academy of Sciences ·Lidia Karabon, Aleksandra Moniewska, Anna Łaba, Cezary Swider, Andrzej Lange	1995	7
20	Presence of mRNA for interferon-gamma (IFN-γ) in blood mononuclear cells is associated with an active stage I sarcoidosis Clinical & Experimental Immunology ·Cezary Swider, Anna Łaba, Aleksandra Moniewska, Johannes Gerdes, H-D. FLAD, Andrzej Lange	1995	10

About Cezary Swider

Cezary Swider is a scholar working on Hematology, Genetics, Periodontics, Emergency Medicine and Rheumatology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Retinoids in leukemia and cellular processes (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), Protein Degradation and Inhibitors (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (494 citations), Genetics (201 citations), Cancer Research (191 citations), Oncology (239 citations) and Immunology (175 citations). Cezary Swider has collaborated with scholars based in United States, Poland and Germany. Frequent co-authors include Martin Carroll, Robin Perry, Kathleen M. Murphy, Gwenn Danet-Desnoyers, Jean‐Emmanuel Sarry, Alexander E. Perl, Andrzej Lange, Elizabeth O. Hexner, Johannes Gerdes and Anthony Secreto. Their work appears in journals such as Blood, Clinical Cancer Research, mAbs, Cancer Biology & Therapy and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact